BRCA1 and breast carcinoma: BRCA1 expression is negatively regulated by the microRNA miR-182; hence miR-182 overexpression sensitizes BRCA1-proficient breast cancer cells to PARPi, whereas its downregulation made them resistant to PARPi (Moskwa et al., 2011; Figure 1, step D, arrow #3).